Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis

Published:2024-08-14 Issue:10 Volume:41 Page:3749-3756
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Karakasis Paschalis^ORCID,Fragakis Nikolaos,Patoulias Dimitrios,Theofilis Panagiotis,Kassimis George,Karamitsos Theodoros,El-Tanani Mohamed,Rizzo Manfredi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02959-x.pdf

Reference39 articles.

1. Mensah GA, Fuster V, Murray CJL, et al. Global burden of cardiovascular diseases and risks, 1990–2022. J Am Coll Cardiol. 2023;82:2350–473. https://doi.org/10.1016/J.JACC.2023.11.007.

2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93-621. https://doi.org/10.1161/CIR.0000000000001123.

3. Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24:1555–66. https://doi.org/10.1177/2047487317715769.

4. Zafeiropoulos S, Doundoulakis I, Bekiaridou A, et al. Rhythm vs rate control strategy for atrial fibrillation: a meta-analysis of randomized controlled trials. JACC Clin Electrophysiol. 2024. https://doi.org/10.1016/j.jacep.2024.03.006.

5. Marrouche NF, Brachmann J. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF)—study design. Pacing Clin Electrophysiol. 2009;32:987–94. https://doi.org/10.1111/j.1540-8159.2009.02428.x.